Australia's largest stock trading and investment forum Australia's #1 stock forum

EYE

0.00%

18.0¢ nova eye medical limited

Solid downtrend here mate

First 756 Last

Share
Profile

Follow
JabraD

15,516 Posts.

1283

15/06/23

15:43

Post #: 68306063
Share

Originally posted by TheAnalyst007: ↑

Agreed, I've certainly been taking the opportunity to purchase more shares as I am very confident that iTrack Advance will be a strong performer and that 2RT will achieve a partnership in the near term. All the feedback from early iTrack Advance users has been extremely positive

The sales update will include sales for the half year through to June 30. This means it will include the very early adoption, but most of it will be pre-FDA approval. We need to wait for 1H FY24 (December) to properly understand what uptake is like. Im hoping they include guidance though as this will help the market better price this company.

Of course there's still 2RT, which is where any major share price rerate is most likely to come from. A partnership announcement could come any day, and depending on what terms of the arrangement are this could be a massive catalyst event. iTrack Advance will likely deliver slower but sustained share price growth rather than a sudden and sharp rerate imo

Expand

Solid downtrend here mate

EYE Price at posting: 26.5¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 2,432 more messages in this thread...

First 756 Last

Add EYE (ASX) to my watchlist

(20min delay)
Last 18.0¢		Change 0.000(0.00%)		Mkt cap ! $41.23M

Open	High	Low	Value	Volume
19.0¢	19.0¢	18.0¢	$24.11K	132.1K

Buyers (Bids)

No.	Vol.	Price($)
4	137086	17.5¢

Sellers (Offers)

Price($)	Vol.	No.
18.5¢	30000	1

View Market Depth

No.	Vol.	Price($)
2	70000	0.175
5	102280	0.170
4	114241	0.165
9	297300	0.160
1	10000	0.155

Price($)	Vol.	No.
0.185	30000	1
0.190	120204	4
0.200	93423	2
0.205	15050	1
0.215	204291	4

Last trade - 14.41pm 04/10/2024 (20 minute delay)

EYE (ASX) Chart

Solid downtrend here mate

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Solid downtrend here mate

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News